Tailored blood thinning helps man, 65, with ITP, recurrent strokes
A man in his 60s with immune thrombocytopenia (ITP) experienced repeated strokes even while taking anticoagulant medications — commonly known as blood thinners —…
Margarida Maia, PhD, —
Articles by Margarida Maia
Research finds bleeding severity varies widely in type 2 VWD
The severity of bleeding in type 2 von Willebrand disease (VWD) can vary widely between subtypes and even among patients who carry the same…
1st BTK inhibitor rilzabrutinib, now Wayrilz, approved in US for ITP
Note: This story was updated Sept. 2, 2025, to clarify the definition of a durable platelet response used in LUNA 3. The U.S. Food and…
New funding will launch trial of tAN for heavy menstrual bleeding
Spark Biomedical has been awarded funding from The Missed Vital Sign, Wellcome Leap’s $50 million program in women’s health, which it will use…
High blood pressure may have no effect on acute TTP recovery
There appears to be no link between high blood pressure in the first two days after an acute episode of thrombotic thrombocytopenic purpura (TTP)…
High LDH may signal mortality risk in immune-mediated TTP
High levels of lactate dehydrogenase (LDH) in the blood — a sign that tissues and organs may have been damaged — may also signal a…
Doptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved in the U.S. for children…
Hetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
